Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-β via Smad3 acetylation

por Osseni, Alexis, Ravel-Chapuis, Aymeric, Belotti, Edwige, Scionti, Isabella, Gangloff, Yann-Gaël, Moncollin, Vincent, Mazelin, Laetitia, Mounier, Remi, Leblanc, Pascal, Jasmin, Bernard J., Schaeffer, Laurent
Publicado 2022

Lack of muscle mTOR kinase activity causes early onset myopathy and compromises whole‐body homeostasis

por Zhang, Qing, Duplany, Agnès, Moncollin, Vincent, Mouradian, Sandrine, Goillot, Evelyne, Mazelin, Laetitia, Gauthier, Karine, Streichenberger, Nathalie, Angleraux, Céline, Chen, Jie, Ding, Shuzhe, Schaeffer, Laurent, Gangloff, Yann‐Gaël
Publicado 2018

Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy

por Risson, Valérie, Mazelin, Laetitia, Roceri, Mila, Sanchez, Hervé, Moncollin, Vincent, Corneloup, Claudine, Richard-Bulteau, Hélène, Vignaud, Alban, Baas, Dominique, Defour, Aurélia, Freyssenet, Damien, Tanti, Jean-François, Le-Marchand-Brustel, Yannick, Ferrier, Bernard, Conjard-Duplany, Agnès, Romanino, Klaas, Bauché, Stéphanie, Hantaï, Daniel, Mueller, Matthias, Kozma, Sara C., Thomas, George, Rüegg, Markus A., Ferry, Arnaud, Pende, Mario, Bigard, Xavier, Koulmann, Nathalie, Schaeffer, Laurent, Gangloff, Yann-Gaël
Publicado 2009